12 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp07477 | (LLKK)4 linear peptide | LLKKLLKKLLKKLLKK | Synthetic | Apoptosis, drug-resistance reversal, tumor suppression | MTT assay | SK-HEP-1 | Liver Cancer | Cell Viability (%) ~ 14.1 ± 0.8 at 30 µg/mL |
| dbacp07478 | (LLKK)4 linear peptide | LLKKLLKKLLKKLLKK | Synthetic | Apoptosis, drug-resistance reversal, tumor suppression | MTT assay | HCT-116 | Colon Cancer | Cell Viability (%) ~ 10.73 ± 2.4 at 30 µg/mL |
| dbacp07479 | (LLKK)4 linear peptide | LLKKLLKKLLKKLLKK | Synthetic | Apoptosis, drug-resistance reversal, tumor suppression | MTT assay | Bcap-37 | Breast Cancer | Cell Viability (%) ~ 15.07 ± 0.5 at 30 µg/mL |
| dbacp07480 | (LLKK)4 linear peptide | LLKKLLKKLLKKLLKK | Synthetic | Apoptosis, drug-resistance reversal, tumor suppression | MTT assay | PC-3 | Prostate Cancer | Cell Viability (%) ~ 17.1 ± 5.0 at 30 µg/mL |
| dbacp07481 | 2-arm branched peptide | [LLKKLLKK]2kC | Synthetic | Apoptosis, drug-resistance reversal, tumor suppression | MTT assay | SK-HEP-1 | Liver Cancer | Cell Viability (%) ~ 85.7 ± 4.3 at 30 µg/mL |
| dbacp07482 | 2-arm branched peptide | [LLKKLLKK]2kC | Synthetic | Apoptosis, drug-resistance reversal, tumor suppression | MTT assay | HCT-116 | Colon Cancer | Cell Viability (%) ~ 78.6 ± 10.5 at 30 µg/mL |
| dbacp07483 | 2-arm branched peptide | [LLKKLLKK]2kC | Synthetic | Apoptosis, drug-resistance reversal, tumor suppression | MTT assay | Bcap-37 | Breast Cancer | Cell Viability (%) ~ 81.8 ± 8.8 at 30 µg/mL |
| dbacp07484 | 2-arm branched peptide | [LLKKLLKK]2kC | Synthetic | Apoptosis, drug-resistance reversal, tumor suppression | MTT assay | PC-3 | Prostate Cancer | Cell Viability (%) ~ 73.5 ± 2.2 at 30 µg/mL |
| dbacp07485 | 4-arm branched peptide | {[LLKKLLKK]2kC}2 | Synthetic | Apoptosis, drug-resistance reversal, tumor suppression | MTT assay | SK-HEP-1 | Liver Cancer | Cell Viability (%) ~ 31.7 ± 5.1 at 30 µg/mL |
| dbacp07486 | 4-arm branched peptide | {[LLKKLLKK]2kC}2 | Synthetic | Apoptosis, drug-resistance reversal, tumor suppression | MTT assay | HCT-116 | Colon Cancer | Cell Viability (%) ~ 67.6 ± 5.8 at 30 µg/mL |
| dbacp07487 | 4-arm branched peptide | {[LLKKLLKK]2kC}2 | Synthetic | Apoptosis, drug-resistance reversal, tumor suppression | MTT assay | Bcap-37 | Breast Cancer | Cell Viability (%) ~ 51.4 ± 4.2 at 30 µg/mL |
| dbacp07488 | 4-arm branched peptide | {[LLKKLLKK]2kC}2 | Synthetic | Apoptosis, drug-resistance reversal, tumor suppression | MTT assay | PC-3 | Prostate Cancer | Cell Viability (%) ~ 49.0 ± 0.8 at 30 µg/mL |